HIF1α, activated by myocardial infarction (MI)/hypoxia, bound to the FTO promoter to decrease its expression, causing aberrant m6A modification, while FTO-mediated m6A modification of EPRS, regulated by IGF2BP3, played a key role in cardiac fibrosis after MI [33]. The gene discussed is FTO; the disease is fibrosis.